The drug inhibits the growth of cancer cells, and in human trials in terminal ovarian cancer patients, tumor size was reduced in 30 % of cases. Furthermore, the drug's side effects were not as extreme as those of conventional chemotherapy.
由於它對癌細胞具有抑製作用，接受人體實驗的末期卵巢癌患者，有百分之三十腫瘤縮小，它的副作用又不似化學治療反應劇烈。